Skip to main content
Top
Published in: Clinical and Experimental Medicine 3/2016

01-08-2016 | Original Article

HFE p.C282Y gene variant is associated with varicose veins in Russian population

Authors: Ekaterina A. Sokolova, Alexandra S. Shadrina, Kseniya S. Sevost’ianova, Andrey I. Shevela, Evgenii Yu. Soldatsky, Evgenii I. Seliverstov, Marina Yu. Demekhova, Oleg A. Shonov, Evgenii A. Ilyukhin, Mariya A. Smetanina, Elena N. Voronina, Igor A. Zolotukhin, Maxim L. Filipenko

Published in: Clinical and Experimental Medicine | Issue 3/2016

Login to get access

Abstract

Recently, the association of polymorphism rs1800562 (p.C282Y) in the hemochromatosis (HFE) gene with the increased risk of venous ulceration was shown. We hypothesized that HFE gene polymorphism might be involved not only in ulceration process, but also in susceptibility to primary varicose veins. We genotyped HFE p.C282Y (rs1800562) and p.H63D (rs1799945) variants in patients with primary varicose veins (n = 463) and in the control group (n = 754). In our study, p.282Y variant (rs1800562 A allele) was significantly associated with the risk of varicose veins (OR 1.79, 95 % CI = 1.11–2.89, P = 0.02). A borderline significant reverse association of p.63D variant (rs1799945 G allele) with venous leg ulcer development was revealed in Russians (OR 0.25, 95 % CI = 0.06–1.00, P = 0.05), but not in the meta-analysis (P = 0.56). We conclude that the HFE gene polymorphism can affect the risk of developing primary varicose veins.
Literature
1.
2.
3.
go back to reference Fowkes FG, Evans CJ, Lee AJ. Prevalence and risk factors of chronic venous insufficiency. Angiology. 2001;52(Suppl 1):S5–15.CrossRefPubMed Fowkes FG, Evans CJ, Lee AJ. Prevalence and risk factors of chronic venous insufficiency. Angiology. 2001;52(Suppl 1):S5–15.CrossRefPubMed
4.
go back to reference Ruckley CV, Evans CJ, Allan PL, et al. Chronic venous insufficiency: clinical and duplex correlations. The Edinburgh Vein Study of venous disorders in the general population. J Vasc Surg. 2002;36:520–5.CrossRefPubMed Ruckley CV, Evans CJ, Allan PL, et al. Chronic venous insufficiency: clinical and duplex correlations. The Edinburgh Vein Study of venous disorders in the general population. J Vasc Surg. 2002;36:520–5.CrossRefPubMed
5.
go back to reference Savel’ev VS, Kirienko AI, Zolotukhin IA,SeliverstovEI (2012) Prospektivnoe observatsionnoe issledovanie SPEKTR: registr patsientov c khronicheskimi zabolevaniyami ven nizhnikh konechnostey (The prospective observational study SPEKTR: the registry of the patients presenting with chronic venous diseases of the lower). Flebologiya 6: 4–9. Savel’ev VS, Kirienko AI, Zolotukhin IA,SeliverstovEI (2012) Prospektivnoe observatsionnoe issledovanie SPEKTR: registr patsientov c khronicheskimi zabolevaniyami ven nizhnikh konechnostey (The prospective observational study SPEKTR: the registry of the patients presenting with chronic venous diseases of the lower). Flebologiya 6: 4–9.
6.
go back to reference Arnoldi CC. The heredity of venous insufficiency. Dan Med Bull. 1958;5:169–76.PubMed Arnoldi CC. The heredity of venous insufficiency. Dan Med Bull. 1958;5:169–76.PubMed
7.
go back to reference Mayall RC. Varicose disease considered as hereditary clinical disease. Resen Clin Cient. 1968;37:28–9.PubMed Mayall RC. Varicose disease considered as hereditary clinical disease. Resen Clin Cient. 1968;37:28–9.PubMed
8.
go back to reference Chatard H. Should the topography of hereditary varices be considered from the genetic angle? Phlebologie. 1968;21(3):303.PubMed Chatard H. Should the topography of hereditary varices be considered from the genetic angle? Phlebologie. 1968;21(3):303.PubMed
9.
10.
go back to reference Cornu-Thenard A, Boivin P, Baud JM, et al. Importance of the familial factor in varicose disease. Clinical study of 134 families. J Dermatol Surg Oncol. 1994;20:318–26.CrossRefPubMed Cornu-Thenard A, Boivin P, Baud JM, et al. Importance of the familial factor in varicose disease. Clinical study of 134 families. J Dermatol Surg Oncol. 1994;20:318–26.CrossRefPubMed
11.
go back to reference Pistorius MA. Chronic venous insufficiency: the genetic influence. Angiology. 2003;54(Suppl 1):S5–12.CrossRefPubMed Pistorius MA. Chronic venous insufficiency: the genetic influence. Angiology. 2003;54(Suppl 1):S5–12.CrossRefPubMed
12.
go back to reference Coon WW. Willis PW3rd, Keller JB. Venous thromboembolism and other venous disease in the Tecumseh community health study. Circulation. 1973;48:839–46.CrossRefPubMed Coon WW. Willis PW3rd, Keller JB. Venous thromboembolism and other venous disease in the Tecumseh community health study. Circulation. 1973;48:839–46.CrossRefPubMed
13.
go back to reference Guberan E, Widmer LK, Glaus L, et al. Causative factors of varicose veins: myths and facts. An epidemiological study of 610 women. Vasa. 1973;2:115–20.PubMed Guberan E, Widmer LK, Glaus L, et al. Causative factors of varicose veins: myths and facts. An epidemiological study of 610 women. Vasa. 1973;2:115–20.PubMed
14.
go back to reference Da Silva A, Widmer LK, Martin H, et al. Varicose veins and chronic venous insufficiency. Vasa. 1974;3:118–25.PubMed Da Silva A, Widmer LK, Martin H, et al. Varicose veins and chronic venous insufficiency. Vasa. 1974;3:118–25.PubMed
15.
go back to reference Brand FN, Dannenberg AL, Abbott RD, Kannel WB. The epidemiology of varicose veins: the Framingham Study. Am J Prev Med. 1988;4:96–101.PubMed Brand FN, Dannenberg AL, Abbott RD, Kannel WB. The epidemiology of varicose veins: the Framingham Study. Am J Prev Med. 1988;4:96–101.PubMed
16.
go back to reference Nelzen O, Bergqvist D, Lindhagen A. The prevalence of chronic lower-limb ulceration has been underestimated: results of a validated population questionnaire. Br J Surg. 1996;83:255–8.CrossRefPubMed Nelzen O, Bergqvist D, Lindhagen A. The prevalence of chronic lower-limb ulceration has been underestimated: results of a validated population questionnaire. Br J Surg. 1996;83:255–8.CrossRefPubMed
18.
go back to reference Görmüş U, Kahraman ÖT, İsbir S, et al. MMP2 gene polymorphisms and MMP2 mRNA levels in patients with superficial varices of lower extremities. Vivo. 2011;25(3):387–91. Görmüş U, Kahraman ÖT, İsbir S, et al. MMP2 gene polymorphisms and MMP2 mRNA levels in patients with superficial varices of lower extremities. Vivo. 2011;25(3):387–91.
19.
go back to reference Katrancioglu N, Manduz S, Ozen F, et al. Type I plasminogen activator inhibitor 4G allele frequency is associated with chronic venous insufficiency. J Int Med Res. 2010;38:1513–8.CrossRefPubMed Katrancioglu N, Manduz S, Ozen F, et al. Type I plasminogen activator inhibitor 4G allele frequency is associated with chronic venous insufficiency. J Int Med Res. 2010;38:1513–8.CrossRefPubMed
20.
go back to reference Sverdlova AM, Bubnova NA, Baranovskaya SS, et al. Prevalence of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with varicose veins of lower limbs. Mol Genet Metab. 1998;63:35–6.CrossRefPubMed Sverdlova AM, Bubnova NA, Baranovskaya SS, et al. Prevalence of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with varicose veins of lower limbs. Mol Genet Metab. 1998;63:35–6.CrossRefPubMed
22.
go back to reference Nagy N, Szolnoky G, Szabad G, et al. Single nucleotide polymorphisms of the fibroblast growth factor receptor 2 gene in patients with chronic venous insufficiency with leg ulcer. J Invest Dermatol. 2005;124:1085–8.CrossRefPubMed Nagy N, Szolnoky G, Szabad G, et al. Single nucleotide polymorphisms of the fibroblast growth factor receptor 2 gene in patients with chronic venous insufficiency with leg ulcer. J Invest Dermatol. 2005;124:1085–8.CrossRefPubMed
23.
go back to reference Hafner J, Kühne A, Schär B, et al. Factor V Leiden mutation in postthrombotic and non-postthrombotic venous ulcers. Arch Dermatol. 2001;137:599–603.PubMed Hafner J, Kühne A, Schär B, et al. Factor V Leiden mutation in postthrombotic and non-postthrombotic venous ulcers. Arch Dermatol. 2001;137:599–603.PubMed
24.
go back to reference Gaber Y, Siemens HJ, Schmeller W. Resistance to activated protein C due to factor V Leiden mutation: high prevalence in patients with post-thrombotic leg ulcers. Br J Dermatol. 2001;144:546–8.CrossRefPubMed Gaber Y, Siemens HJ, Schmeller W. Resistance to activated protein C due to factor V Leiden mutation: high prevalence in patients with post-thrombotic leg ulcers. Br J Dermatol. 2001;144:546–8.CrossRefPubMed
25.
go back to reference Maessen-Visch MB, Hamulyak K, Tazelaar DJ, et al. The prevalence of factor V Leiden mutation in patients with leg ulcers and venous insufficiency. Arch Dermatol. 1999;135:41–4.CrossRefPubMed Maessen-Visch MB, Hamulyak K, Tazelaar DJ, et al. The prevalence of factor V Leiden mutation in patients with leg ulcers and venous insufficiency. Arch Dermatol. 1999;135:41–4.CrossRefPubMed
26.
go back to reference Peus D, Heit JA, Pittelkow MR. Activated protein C resistance caused by factor V gene mutation: common coagulation defect in chronic venous leg ulcers? J Am Acad Dermatol. 1997;36:616–20.CrossRefPubMed Peus D, Heit JA, Pittelkow MR. Activated protein C resistance caused by factor V gene mutation: common coagulation defect in chronic venous leg ulcers? J Am Acad Dermatol. 1997;36:616–20.CrossRefPubMed
29.
go back to reference Zamboni P, Tognazzo S, Izzo M, et al. Hemochromatosis C282Y gene mutation increases the risk of venous leg ulceration. J Vasc Surg. 2005;42:309–14.CrossRefPubMed Zamboni P, Tognazzo S, Izzo M, et al. Hemochromatosis C282Y gene mutation increases the risk of venous leg ulceration. J Vasc Surg. 2005;42:309–14.CrossRefPubMed
30.
go back to reference Yeoh-Ellerton S, Stacey M. Iron and 8-Isoprostane levels in acute and chronic wounds. J Invest Dermatol. 2003;121(4):918–25.CrossRefPubMed Yeoh-Ellerton S, Stacey M. Iron and 8-Isoprostane levels in acute and chronic wounds. J Invest Dermatol. 2003;121(4):918–25.CrossRefPubMed
32.
go back to reference Kartikasari AE, Georgiou NA, Visseren FLJ, et al. Endothelial activation and induction of monocyte adhesion by nontransferrin-bound iron present in human sera. FASEB J. 2006;20:353–5.PubMed Kartikasari AE, Georgiou NA, Visseren FLJ, et al. Endothelial activation and induction of monocyte adhesion by nontransferrin-bound iron present in human sera. FASEB J. 2006;20:353–5.PubMed
33.
go back to reference Eklöf B, Rutherford RB, Bergan JJ, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004;40(6):1248–52.CrossRefPubMed Eklöf B, Rutherford RB, Bergan JJ, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004;40(6):1248–52.CrossRefPubMed
34.
go back to reference Kirienko AI, Bogachev VIu, Gavrilov SG, et al. Chronic diseases of lower extremity veins in industrial workers of Moscow (results of the epidemiological survey). Angiol Sosud Khir. 2004;10(1):77–85.PubMed Kirienko AI, Bogachev VIu, Gavrilov SG, et al. Chronic diseases of lower extremity veins in industrial workers of Moscow (results of the epidemiological survey). Angiol Sosud Khir. 2004;10(1):77–85.PubMed
35.
go back to reference Saveliev VS, Kirienko AI, Zolotukhin IA, Seliverstov EI. Prospective observational study SPECTRUM: the registry of patients with chronic venous diseases. Flebologia. 2012;6(1):4–9. Saveliev VS, Kirienko AI, Zolotukhin IA, Seliverstov EI. Prospective observational study SPECTRUM: the registry of patients with chronic venous diseases. Flebologia. 2012;6(1):4–9.
36.
go back to reference Abbade LP, Lastória S. Venous ulcer: epidemiology, physiopathology, diagnosis and treatment. Int J Dermatol. 2005;44:449–56.CrossRefPubMed Abbade LP, Lastória S. Venous ulcer: epidemiology, physiopathology, diagnosis and treatment. Int J Dermatol. 2005;44:449–56.CrossRefPubMed
37.
go back to reference Zamboni P, Izzo M, Tognazzo S, et al. The overlapping of local iron overload and HFE mutation in venous leg ulcer pathogenesis. Free Radic Biol Med. 2006;40:1869–73.CrossRefPubMed Zamboni P, Izzo M, Tognazzo S, et al. The overlapping of local iron overload and HFE mutation in venous leg ulcer pathogenesis. Free Radic Biol Med. 2006;40:1869–73.CrossRefPubMed
44.
go back to reference Budzyń M, Iskra M, Krasiński Z, et al. Serum iron concentration and plasma oxidant-antioxidant balance in patients with chronic venous insufficency. Med Sci Monit. 2011;17(12):CR719–27.PubMedPubMedCentral Budzyń M, Iskra M, Krasiński Z, et al. Serum iron concentration and plasma oxidant-antioxidant balance in patients with chronic venous insufficency. Med Sci Monit. 2011;17(12):CR719–27.PubMedPubMedCentral
45.
go back to reference Zamboni P, Scapoli G, Lanzara V, et al. (2005) Serum iron and matrix metalloproteinase-9 variations in limbs affected by chronic venous disease and venous leg ulcers. Dermatol Surg. 31:644–9, discussion 649. Zamboni P, Scapoli G, Lanzara V, et al. (2005) Serum iron and matrix metalloproteinase-9 variations in limbs affected by chronic venous disease and venous leg ulcers. Dermatol Surg. 31:644–9, discussion 649.
46.
go back to reference Ackerman Z, Seidenbaum M, Loewenthal E, Rubinow A. Overload of iron in the skin of patients with varicose ulcers. Possible contributing role of iron accumulation in progression of the disease. Arch Dermatol. 1988;124:1376–8.CrossRefPubMed Ackerman Z, Seidenbaum M, Loewenthal E, Rubinow A. Overload of iron in the skin of patients with varicose ulcers. Possible contributing role of iron accumulation in progression of the disease. Arch Dermatol. 1988;124:1376–8.CrossRefPubMed
47.
go back to reference Morrison HI, Semenciw RM, Mao Y, Wigle DT. Serum iron and risk of fatal acute myocardial infarction. Epidemiology. 1994;5:243–6.CrossRefPubMed Morrison HI, Semenciw RM, Mao Y, Wigle DT. Serum iron and risk of fatal acute myocardial infarction. Epidemiology. 1994;5:243–6.CrossRefPubMed
48.
go back to reference De Valk B, Marx JJ. Iron, atherosclerosis, and ischemic heart disease. Arch Intern Med. 1999;159:1542–8.CrossRefPubMed De Valk B, Marx JJ. Iron, atherosclerosis, and ischemic heart disease. Arch Intern Med. 1999;159:1542–8.CrossRefPubMed
50.
go back to reference Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399–408.CrossRefPubMed Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399–408.CrossRefPubMed
Metadata
Title
HFE p.C282Y gene variant is associated with varicose veins in Russian population
Authors
Ekaterina A. Sokolova
Alexandra S. Shadrina
Kseniya S. Sevost’ianova
Andrey I. Shevela
Evgenii Yu. Soldatsky
Evgenii I. Seliverstov
Marina Yu. Demekhova
Oleg A. Shonov
Evgenii A. Ilyukhin
Mariya A. Smetanina
Elena N. Voronina
Igor A. Zolotukhin
Maxim L. Filipenko
Publication date
01-08-2016
Publisher
Springer International Publishing
Published in
Clinical and Experimental Medicine / Issue 3/2016
Print ISSN: 1591-8890
Electronic ISSN: 1591-9528
DOI
https://doi.org/10.1007/s10238-015-0377-y

Other articles of this Issue 3/2016

Clinical and Experimental Medicine 3/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.